Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.AWHL · Entity 7871 | Director | September 19, 2025 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date September 19, 2025 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 386,018 |
Reported balance
After 2025-09-17 transaction · row 1
1 source rowRow 1 · 2025-09-17 · Other · Acquired 11,112 · Balance 386,018 F1: The shares were acquired as payment to Dr. Cohen from another party in settlement of another property. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 71,010 |
Reported balance
Holding disclosure · report date 2025-09-19 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 71,010 |
| Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2030-09-17 | Direct | 41,667 |
Reported balance
Holding disclosure · report date 2025-09-19 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 41,667 |
| Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.35 · Expires 2031-03-05 | Direct | 450,318 |
Reported balance
Holding disclosure · report date 2025-09-19 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 450,318 |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were acquired as payment to Dr. Cohen from another party in settlement of another property.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2025 Filed Dec 4, 2025 02:30 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | GrantStock Option (Right to Buy) · Derivative | 213,518 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001493152-25-026074 · ownership.xml · derivative · entry 1 cohen Jeffrey k · CIK 0002071174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,518 Underlying: Common Stock · 213,518 shares Expires 2035-12-02 Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 21:26 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | PurchaseWarrant (Right to Buy) · Derivative | 41,667 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001493152-25-014333 · ownership.xml · derivative · entry 3 cohen Jeffrey k · CIK 0002071174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 491,985 Underlying: Common Stock, par value $0.001 · 41,667 shares Expires 2030-09-17 Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 21:26 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | PurchaseCommon Stock | 55,556 | $0.45 | $25,000.20 |
DisclosureSEC source: 0001493152-25-014333 · ownership.xml · nonDerivative · entry 1 cohen Jeffrey k · CIK 0002071174 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By HealthView Asset Management Disclosed balance after: 375,697 Read SEC document |
| September 17, 2025 Filed May 29, 2026 20:07 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | OtherCommon Stock | 11,112 | $0.45 | $5,000.40 |
DisclosureSEC source: 0001493152-26-026359 · ownership.xml · nonDerivative · entry 1 cohen Jeffrey k · CIK 0002071174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,018 F1 · kind: The shares were acquired as payment to Dr. Cohen from another party in settlement of another property. Read SEC document |
| September 17, 2025 Filed May 29, 2026 20:05 UTC Amendment | Aspira Women's Health Inc. AWHL · Entity 7871 | PurchaseWarrant (Right to Buy) · Derivative | 41,667 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001493152-26-026345 · ownership.xml · derivative · entry 3 cohen Jeffrey k · CIK 0002071174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,667 Underlying: Common Stock, par value $0.001 · 41,667 shares Expires 2030-09-17 F1 · balance_after: This report is being filed to correct the number and nature of shares held by Dr. Cohen on September 17, 2025, the number of shares held by Dr. Cohen's spouse on September 17, 2025 and the presentation of the warrants held on September 17, 2025. Read SEC document |
| September 17, 2025 Filed May 29, 2026 20:05 UTC Amendment | Aspira Women's Health Inc. AWHL · Entity 7871 | PurchaseCommon Stock | 55,556 | $0.45 | $25,000.20 |
DisclosureSEC source: 0001493152-26-026345 · ownership.xml · nonDerivative · entry 1 cohen Jeffrey k · CIK 0002071174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,906 F1 · balance_after: This report is being filed to correct the number and nature of shares held by Dr. Cohen on September 17, 2025, the number of shares held by Dr. Cohen's spouse on September 17, 2025 and the presentation of the warrants held on September 17, 2025. Read SEC document |
| May 13, 2025 Filed Jun 4, 2025 23:21 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | GrantCommon Stock | 11,653 | $0.07 | $815.71 |
DisclosureSEC source: 0001641172-25-013689 · ownership.xml · nonDerivative · entry 2 cohen Jeffrey k · CIK 0002071174 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 60,913 Read SEC document |
| May 09, 2025 Filed Jun 4, 2025 23:21 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | GrantCommon Stock | 44,260 | $0.07 | $3,098.20 |
DisclosureSEC source: 0001641172-25-013689 · ownership.xml · nonDerivative · entry 1 cohen Jeffrey k · CIK 0002071174 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 49,260 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.